Literature DB >> 26379830

Gene function analysis in osteosarcoma based on microarray gene expression profiling.

Liang Zhao1, Jinghua Zhang2, Hongyu Tan1, Weidong Wang1, Yilin Liu1, Ruipeng Song1, Limin Wang1.   

Abstract

Osteosa rcoma is an aggressive malignant neoplasm that exhibits osteoblastic differentiation and produces malignant osteoid. The aim of this study was to find feature genes associated with osteosarcoma and correlative gene functions which can distinguish cancer tissues from non-tumor tissues. Gene expression profile GSE14359 was downloaded from Gene Expression Omnibus (GEO) database, including 10 osteosarcoma samples and 2 normal samples. The differentially expressed genes (DEGs) between osteosarcoma and normal specimens were identified using limma package of R. DAVID was applied to mine osteosarcoma associated genes and analyze the GO enrichment on gene functions and KEGG pathways. Then, corresponding protein-protein interaction (PPI) network of DEGs was constructed based on the data collected from STRING datasets. Principal component of top10 DEGs and PPI network of top 20 DEGs were further analyzed. Finally, transcription factors were predicted by uploading the two groups of DEGs to TfactS database. A total of 437 genes, including 114 up-regulated genes and 323 down-regulated genes, were filtered as DEGs, of which 46 were associated with osteosarcoma by Disease Module. GO and KEGG pathway enrichment analysis showed that genes mainly affected the process of immune response and the development of skeletal and vascular system. The PPI network analysis elucidated that hemoglobin and histocompatibility proteins and enzymes, which were associated with immune response, were closely associated with osteosarcoma. Transcription factors MYC and SP1 were predicted to be significantly related to osteosarcoma. The discovery of gene functions and transcription factors has the potential to use in clinic for diagnosis of osteosarcoma in future. In addition, it will pave the way to studying mechanism and effective therapies for osteosarcoma.

Entities:  

Keywords:  DEGs; GO enrichment; Osteosarcoma; PPI network; transcription factors

Year:  2015        PMID: 26379830      PMCID: PMC4565213     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Identification of transcription factor binding sites derived from transposable element sequences using ChIP-seq.

Authors:  Andrew B Conley; I King Jordan
Journal:  Methods Mol Biol       Date:  2010

Review 2.  Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?

Authors:  Matthew C Lucas; Seng-Lai Tan
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

Review 3.  Receptor tyrosine kinases in osteosarcoma: not just the usual suspects.

Authors:  Ashley N Rettew; Patrick J Getty; Edward M Greenfield
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 4.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.

Authors:  Jinglei Miao; Song Wu; Zhi Peng; Mousumi Tania; Chaoyue Zhang
Journal:  Tumour Biol       Date:  2013-08

Review 5.  EMT transcription factors: implication in osteosarcoma.

Authors:  Guoqiong Yang; Jian Yuan; Kanghua Li
Journal:  Med Oncol       Date:  2013-08-24       Impact factor: 3.064

6.  Principal components analysis to summarize microarray experiments: application to sporulation time series.

Authors:  S Raychaudhuri; J M Stuart; R B Altman
Journal:  Pac Symp Biocomput       Date:  2000

7.  At-risk populations for osteosarcoma: the syndromes and beyond.

Authors:  George T Calvert; R Lor Randall; Kevin B Jones; Lisa Cannon-Albright; Stephen Lessnick; Joshua D Schiffman
Journal:  Sarcoma       Date:  2012-03-12

8.  Assessing the percent of necrosis after neoadjuvant chemotherapy with 24hr infusional cisplatin/3 days Doxorubicin intermittent with Ifosfamide-Doxorubicin for osteosarcoma.

Authors:  Mozhgan Aalam Samimi; Nooshin Mirkheshti; Abdolreza Pazouki
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

9.  Serum starvation-induced voltage-gated potassium channel Kv7.5 expression and its regulation by Sp1 in canine osteosarcoma cells.

Authors:  Bo Hyung Lee; Pan Dong Ryu; So Yeong Lee
Journal:  Int J Mol Sci       Date:  2014-01-10       Impact factor: 5.923

10.  Classification, imaging, biopsy and staging of osteosarcoma.

Authors:  Zile Singh Kundu
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

View more
  7 in total

1.  Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.

Authors:  Xuan Dung Ho; Phuong Phung; Van Q Le; Van H Nguyen; Ene Reimann; Ele Prans; Gea Kõks; Katre Maasalu; Nghi Tn Le; Le H Trinh; Hoang G Nguyen; Aare Märtson; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2017-10-19

2.  Microarray and bioinformatics analyses of gene expression profiles in BALB/c murine macrophage polarization.

Authors:  Li Jiang; Xueqin Li; Yingying Zhang; Mengying Zhang; Zongsheng Tang; Kun Lv
Journal:  Mol Med Rep       Date:  2017-09-19       Impact factor: 2.952

3.  Triple primary malignancies of surface osteosarcoma of jaw, myelodysplastic syndrome and colorectal cancer as a second primary cancer detected by PET2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography: A case report.

Authors:  Nobuyuki Maruyama; Kazuhide Nishihara; Toshiyuki Nakasone; Masanao Saio; Tessho Maruyama; Iori Tedokon; Tetsuya Ohira; Fumikazu Nimura; Akira Matayoshi; Ken-Nosuke Karube; Naoki Yoshimi; Akira Arasaki
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

4.  Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma.

Authors:  Shengye Liu; Jiamei Liu; Xuechen Yu; Tao Shen; Qin Fu
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

5.  Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma.

Authors:  Yiyang Yu; Hongliang Zhang; Tingting Ren; Yi Huang; Xin Liang; Wei Wang; Jianfang Niu; Yu Han; Wei Guo
Journal:  J Cell Mol Med       Date:  2020-08-21       Impact factor: 5.310

6.  Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients.

Authors:  Kun Wu; Bo Nie; Liyin Li; Xin Yang; Jinrong Yang; Zhenxin He; Yanhong Li; Shenju Cheng; Mingxia Shi; Yun Zeng
Journal:  Ann Transl Med       Date:  2021-10

7.  Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2-p53 signaling.

Authors:  Chuhai Xie; Boyi Wu; Binwei Chen; Qunwei Shi; Jianhong Guo; Ziwen Fan; Yan Huang
Journal:  Onco Targets Ther       Date:  2016-07-04       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.